US EditionRFK Jr.’s CDC vaccine panel backs Merck RSV shot for infants
- On Wednesday, the newly reconstituted Advisory Committee on Immunization Practices , appointed by Health Secretary Robert F. Kennedy Jr., recommended Merck's RSV antibody shot clesrovimab for infants.
- Kennedy dismissed the previous 17-member panel this month, replacing it with a seven-member group including vaccine skeptics, which raised concern among public health experts.
- The committee also discussed thimerosal, a mercury-based vaccine preservative long used to prevent bacterial contamination, despite extensive studies showing no autism link.
- The panel voted 5-2 to add Merck’s clesrovimab to the government-funded initiative that provides free vaccines to children from low-income families, while Dr. Cody Meissner described the vaccine’s impact as a remarkable achievement for public health.
- The committee’s actions could shift vaccine policies and accessibility, prompting warnings from public health leaders who fear ideological changes might limit routine immunizations for millions.
90 Articles
90 Articles
Respiratory syncytial virus entry and how to block it
Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract disease in young children and elderly people. Although the virus was isolated in 1955, an effective RSV vaccine has not been developed, and the only licensed intervention is passive immunoprophylaxis of high-risk infants with a humanized monoclonal antibody. During the past 5 years, however, there has been substantial progress in our understanding of the structure an…
This day Jorge Vilches, head of the Department of Epidemiology, and Valentina Pino, coordinator of the Winter Campaign of the Ministry of Health, announced a new Respiratory Virus Report, corresponding to the epidemiological week 25 -from June 15 to 21-. According to the authorities, during this period the positivity of the samples reached 43.5%, a figure discreetly lower than the one recorded the previous week. “This is 0.2% less regarding the …
RFK Jr.'s vaccine committee advises Merck's RSV shot for babies
(NewsNation) — Health and Human Services Secretary Robert F. Kennedy Jr.'s vaccine committee on Thursday voted to recommend a shot that protects babies against RSV, reports said. The shot, called Enflonsia, is made by Merck. Enflonsia is a preventive, long-acting monoclonal antibody designed to provide rapid protection through five months with the same dose regardless of weight. It is the second RSV monoclonal antibody of its kind on the market.…
Kennedy's Vaccine Panel Backs New RSV Shot
The first vote of Robert F. Kennedy Jr.'s new vaccine panel ended up being a surprising one, reports USA Today . The panel, which includes known vaccine critics , gave the green light to a new shot to protect infants from respiratory syncytial virus (RSV). Though two members disagreed, the Advisory...
A medical panel appointed by Health Secretary Robert F. Kennedy Jr. voted this Thursday for a new anti-RSV antibody treatment, a common respiratory disease that is the main cause of hospitalization of babies in the country.Read more]]>
Coverage Details
Bias Distribution
- 65% of the sources are Center
To view factuality data please Upgrade to Premium
